Sim&Cure
Grabels
About Sim&Cure
Sim&Cure is the first company to be cleared to market a patient-based simulation model for aneurysm treatment that allows prediction of the deployment of medical devices (flow diverter, intrasaccular device, laser-cuter stent). Sim&Size® simulates each size and type of device according to the patient’s unique anatomy in order to provide essential information prior to the choice of sizing.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $15.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2025)
- Website: sim-and-cure.com
- Phone: +33 (0)9 53 40 51 82
Industries & Categories
Health Care, Medical Device, Software
Social Profiles
Canonical: https://fsome.com/organization/sim-cure-5807 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.